1-18 of 18
Anita Boyapati
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Soluble BCMA Dynamics in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1

Anasuya Hazra, Anita Boyapati, Ching-Ha Lai, Kate Knorr, Dhruti Chokshi, Glenn S. Kroog, Karen Rodriguez Lorenc, A. Thomas DiCioccio, John D. Davis
Journal: Blood
Blood (2024) 144 (Supplement 1): 3310.
https://doi.org/10.1182/blood-2024-200880
Published: 2024
Journal Articles

Characterization of Linvoseltamab's BCMA Binding Epitope and Efficacy Against BCMA Mutations in Relapsed/Refractory Multiple Myeloma

Ken Lee, Yi Zhou, Matthew Franklin, Erica Ullman, Aynur Hermann, Glenn S. Kroog, Anita Boyapati, Karen Rodriguez Lorenc, Eric Smith, John Lin, William Olson, Leonardo Andres Sirulnik, Kara Olson
Journal: Blood
Blood (2024) 144 (Supplement 1): 3265.
https://doi.org/10.1182/blood-2024-208776
Published: 2024
Journal Articles

Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-up and Selected High-Risk Subgroup Analyses of the Linker-MM1 Study

Mansi R. Shah, Joshua Richter, Hans C. Lee, Attaya Suvannasankha, James E. Hoffman, Suzanne Lentzsch, Sundar Jagannath, Jeffrey A. Zonder, Rachid Baz, Swathi Namburi, Ka Lung Wu, Madhav V. Dhodapkar, Joseph J. Maly, Rebecca Silbermann, Chang-Ki Min, Matthew Pianko, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Michelle DeVeaux, Dhruti Chokshi, Megan Seraphin, Anita Boyapati, Anasuya Hazra, Glenn S. Kroog, Kate Knorr, Naresh Bumma
Journal: Blood
Blood (2024) 144 (Supplement 1): 3369.
https://doi.org/10.1182/blood-2024-199733
Published: 2024
Journal Articles

Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study

Sundar Jagannath, Joshua Richter, Madhav V. Dhodapkar, James E. Hoffman, Hans C. Lee, Attaya Suvannasankha, Mansi R. Shah, Suzanne Lentzsch, Jeffrey A. Zonder, Rachid Baz, Joseph J. Maly, Swathi Namburi, Ka Lung Wu, Matthew Pianko, Jing Christine Ye, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez Lopez, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S. Kroog, Yariv Houvras, Naresh Bumma
Journal: Blood
Blood (2023) 142 (Supplement 1): 4746.
https://doi.org/10.1182/blood-2023-177968
Published: 2023
Journal Articles

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Naresh Bumma, Joshua Richter, Jason Brayer, Jeffrey A. Zonder, Madhav Dhodapkar, Mansi R. Shah, James E. Hoffman, Raya Mawad, Joseph J. Maly, Suzanne Lentzsch, Attaya Suvannasankha, Pourab Roy, Jyotirmoy Dey, Dhruti Chokshi, Anita Boyapati, Jenn Visich, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 10140–10141.
https://doi.org/10.1182/blood-2022-159969
Published: 2022
Journal Articles

Trial in Progress: A Phase II Window of Opportunity Study of the BCMAxCD3 Bispecific Antibody REGN5458 in Previously Untreated Patients with Symptomatic Multiple Myeloma

Christopher J. Ferreri, Steven E. Quatela, Sean Aina, Pourab Roy, Anita Boyapati, Karen Rodriguez Lorenc, Glenn S. Kroog, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 10129–10130.
https://doi.org/10.1182/blood-2022-158396
Published: 2022
Journal Articles

Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Jeffrey A. Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E Hoffman, William I. Bensinger, Ka Lung Wu, Linzhi Xu, Dhruti Chokshi, Anita Boyapati, Manish Sharma, Karen Rodriguez Lorenc, Glenn S Kroog, Madhav V Dhodapkar, Suzanne Lentzsch, Dennis Cooper, Sundar Jagannath
Journal: Blood
Blood (2021) 138 (Supplement 1): 160.
https://doi.org/10.1182/blood-2021-144921
Published: 2021
Journal Articles

REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Deepu Madduri, MD, Ashley Rosko, MD, Jason Brayer, PhDMD, Jeffrey Zonder, William I. Bensinger, MD, Jingjin Li, PhD, Linzhi Xu, PhD, Lieve Adriaens, PharmD, Dhruti Chokshi, BS, Weijiang Zhang, PhD, Anita Boyapati, PhD, Manish Sharma, MD, Frank Seebach, MD, L. Andres Sirulnik, MD PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Madhav V. Dhodapkar, MD, Suzanne Lentzsch, MD PhD, Dennis Cooper, MD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-139192
Published: 2020
Journal Articles

Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Dennis Cooper, MD, Deepu Madduri, MD, Suzanne Lentzsch, MD PhD, Sundar Jagannath, Jingjin Li, PhD, Anita Boyapati, PhD, Lieve Adriaens, PharmD, Dhruti Chokshi, BS, Min Zhu, PhD, Israel Lowy, MD PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Manish Sharma, MD, Maria Karasarides, PhD, David Sternberg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3176.
https://doi.org/10.1182/blood-2019-126818
Published: 2019
Journal Articles

Disruption of the NHR4 Domain Structure in AML1-ETO Abrogates Its Interaction with SON and Promotes AML1-ETO-Associated Leukemogenesis.

Eun-Young Ahn, PhD, Ming Yan, Ph.D., Oxana A Malakhova, M.S., Anita Boyapati, Ph.D., Hans Beier Ommen, M.D., Robert Hines, Ph.D., Peter Hokland, M.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 936.
https://doi.org/10.1182/blood.V112.11.936.936
Published: 2008
Journal Articles

t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression

Akiko J. Okumura, Luke F. Peterson, Fumihiko Okumura, Anita Boyapati, Dong-Er Zhang
Journal: Blood
Blood (2008) 112 (4): 1392–1401.
https://doi.org/10.1182/blood-2007-11-124735
Published: 2008
Includes: Supplemental data
Journal Articles

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts

Luke F. Peterson, Anita Boyapati, Eun-Young Ahn, Joseph R. Biggs, Akiko Joo Okumura, Miao-Chia Lo, Ming Yan, Dong-Er Zhang
Journal: Blood
Blood (2007) 110 (3): 799–805.
https://doi.org/10.1182/blood-2006-11-019265
Published: 2007
Journal Articles

A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy

Anita Boyapati, Ming Yan, Luke F. Peterson, Joseph R. Biggs, Michelle M. Le Beau, Dong-Er Zhang
Journal: Blood
Blood (2006) 109 (9): 3963–3971.
https://doi.org/10.1182/blood-2006-09-045583
Published: 2006
Includes: Supplemental data
Journal Articles

A t(8;21) Fusion Protein Disrupts the Spindle Checkpoint and Promotes Aneuploidy.

Anita Boyapati, PhD, Luke F. Peterson, PhD, Ming Yan, PhD, Michelle M. Le Beau, PhD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2005) 106 (11): 1345.
https://doi.org/10.1182/blood.V106.11.1345.1345
Published: 2005
Journal Articles

AML1-ETO9a, an Alternatively Spliced Form of AML1-ETO, Collaborates with AML1-ETO To Promote Leukemogenesis.

Ming Yan, PhD, Yang Wang, MD, PhD, Luke F. Peterson, PhD, Eiki Kanbe, MD, PhD, Anita Boyapati, PhD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2005) 106 (11): 661.
https://doi.org/10.1182/blood.V106.11.661.661
Published: 2005
Journal Articles

Differential Effects on Cell Cycle Regulators by AML1-ETO and a C-Terminal Truncated AML1-ETO (From Tumor Suppressor to Oncogene).

Luke F. Peterson, Ph.D., Ming Yan, Ph.D., Anita Boyapati, Ph.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2052.
https://doi.org/10.1182/blood.V104.11.2052.2052
Published: 2004
Journal Articles

The Dimerization Domain and C-Terminal NCoR/SMRT Interacting Zinc-Finger Domain of t(8;21) Fusion Protein AML1-ETO Have Critical and Opposite Effects on Leukemogenesis.

Ming Yan, Ph.D, Eiki Kanbe, M.D.-Ph.D., Luke F. Peterson, Ph.D., Anita Boyapati, Ph.D., Robert Hines, Ph.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2556.
https://doi.org/10.1182/blood.V104.11.2556.2556
Published: 2004
Journal Articles

Identification of a Novel Alternatively Spliced Form of AML1-ETO and Analysis of Its Role in Leukemogenesis.

Eiki Kanbe, M.D.-Ph.D., Yang Wang, M.D.-Ph.D., Anita Boyapati, Ph.D., Ming Yan, Ph.D., Luke F. Peterson, Ph.D., Cheryl L. Willman, M.D., Janet D. Rowley, M.D., Don-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 545.
https://doi.org/10.1182/blood.V104.11.545.545
Published: 2004